Olopatadine hydrochloride decreases tissue interleukin-31 levels in an atopic dermatitis mouse model

Acta Derm Venereol. 2014 Jan;94(1):78-9. doi: 10.2340/00015555-1648.
No abstract available

MeSH terms

  • Animals
  • Anti-Allergic Agents / therapeutic use*
  • Dermatitis, Atopic / complications
  • Dermatitis, Atopic / drug therapy*
  • Dermatitis, Atopic / metabolism*
  • Dibenzoxepins / therapeutic use*
  • Disease Models, Animal
  • Immunosuppressive Agents / therapeutic use
  • Interleukins / metabolism*
  • Mice
  • Olopatadine Hydrochloride
  • Pruritus / etiology
  • Pruritus / metabolism
  • Tacrolimus / therapeutic use

Substances

  • Anti-Allergic Agents
  • Dibenzoxepins
  • Immunosuppressive Agents
  • Interleukins
  • interleukin-31, mouse
  • Olopatadine Hydrochloride
  • Tacrolimus